Stock listing
NASDAQ:IRD Opus Genetics, Inc. Stock
Home listing (NASDAQ) of Opus Genetics, Inc.
Follow Opus Genetics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IRD
$3.67 USD +0.02 (+0.5%)
Close on Oct 30, 2026
- Day range
- $3.42 – $3.69 USDOct 30, 2026
- Volume
- 1.02M sharesOct 30, 2026
- Market cap
- $305.3M USDAt the close on Oct 30, 2026 · price × 83.20M shares outstanding
- 52-week range
- $1.70 – $7.07 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $12.26M USDMedian day 1.32M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IRD · Home | $3.67 USD | +0.02 (+0.5%) | 1,019,544 | $3.58 | $3.69 | $3.42 | $3.65 | Close on Oct 30, 2026 |
| Frankfurt:R3X1 | €3.26 EUR | +0.18 (+5.8%) | — | €3.18 | €3.26 | €3.00 | €3.08 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IRD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.67 | +0.02 | +0.5% | $3.58 | $3.69 | $3.42 | 1,019,544 | |
| $3.65 | -0.03 | -0.8% | $3.68 | $3.82 | $3.60 | 709,585 | |
| $3.68 | +0.22 | +6.4% | $3.44 | $3.69 | $3.40 | 1,033,143 | |
| $3.46 | +0.14 | +4.2% | $3.32 | $3.53 | $3.28 | 1,303,301 | |
| $3.32 | -0.15 | -4.3% | $3.49 | $3.50 | $3.23 | 1,520,145 | |
| $3.47 | -0.35 | -9.2% | $3.79 | $3.83 | $3.44 | 1,115,336 | |
| $3.82 | -0.295 | -7.2% | $4.04 | $4.10 | $3.80 | 894,736 | |
| $4.115 | +0.105 | +2.6% | $4.03 | $4.215 | $4.00 | 1,355,925 | |
| $4.01 | +0.19 | +5.0% | $3.82 | $4.145 | $3.78 | 1,461,227 | |
| $3.82 | -0.02 | -0.5% | $3.87 | $3.94 | $3.69 | 1,527,758 | |
| $3.84 | -0.21 | -5.2% | $4.12 | $4.13 | $3.75 | 2,527,000 | |
| $4.05 | -0.05 | -1.2% | $4.15 | $4.28 | $3.98 | 2,952,900 | |
| $4.10 | -0.14 | -3.3% | $4.40 | $4.40 | $4.08 | 1,198,400 | |
| $4.24 | -0.40 | -8.6% | $4.76 | $4.77 | $4.23 | 1,291,500 | |
| $4.64 | -0.01 | -0.2% | $4.63 | $4.88 | $4.60 | 1,623,200 | |
| $4.65 | +0.19 | +4.3% | $4.46 | $4.74 | $4.45 | 1,255,400 | |
| $4.46 | +0.05 | +1.1% | $4.41 | $4.48 | $4.25 | 1,345,700 | |
| $4.41 | +0.03 | +0.7% | $4.35 | $4.66 | $4.25 | 1,839,800 | |
| $4.38 | 0.00 | 0.0% | $4.47 | $4.48 | $4.19 | 2,534,000 | |
| $4.38 | -0.20 | -4.4% | $4.57 | $4.64 | $4.34 | 2,534,900 | |
| $4.58 | +0.07 | +1.6% | $4.56 | $4.67 | $4.45 | 1,789,500 | |
| $4.51 | -0.33 | -6.8% | $4.89 | $4.91 | $4.51 | 1,873,800 | |
| $4.84 | -0.12 | -2.4% | $4.96 | $5.32 | $4.83 | 2,458,000 | |
| $4.96 | -0.09 | -1.8% | $5.07 | $5.15 | $4.80 | 1,525,100 | |
| $5.05 | +0.29 | +6.1% | $4.75 | $5.14 | $4.63 | 1,161,400 | |
| $4.76 | -0.11 | -2.3% | $4.89 | $4.93 | $4.70 | 1,244,700 | |
| $4.87 | +0.04 | +0.8% | $4.76 | $4.96 | $4.60 | 1,831,200 | |
| $4.83 | -0.33 | -6.4% | $5.14 | $5.16 | $4.65 | 3,055,100 | |
| $5.16 | -0.06 | -1.1% | $5.20 | $5.30 | $5.04 | 1,172,000 | |
| $5.22 | +0.04 | +0.8% | $5.17 | $5.55 | $5.17 | 1,979,800 | |
| $5.18 | -0.10 | -1.9% | $5.29 | $5.34 | $5.11 | 5,541,000 | |
| $5.28 | -0.13 | -2.4% | $5.46 | $5.62 | $5.23 | 1,531,100 | |
| $5.41 | -0.41 | -7.0% | $5.80 | $5.80 | $5.35 | 2,335,200 | |
| $5.82 | -0.15 | -2.5% | $5.94 | $5.95 | $5.67 | 1,991,900 | |
| $5.97 | -0.07 | -1.2% | $6.02 | $6.22 | $5.80 | 2,550,100 | |
| $6.04 | -0.03 | -0.5% | $6.16 | $6.58 | $5.77 | 4,652,000 | |
| $6.07 | +0.34 | +5.9% | $5.87 | $6.24 | $5.40 | 6,536,900 | |
| $5.73 | +1.39 | +32.0% | $5.31 | $7.07 | $5.31 | 54,319,700 | |
| $4.34 | -0.33 | -7.1% | $4.53 | $4.62 | $4.31 | 2,267,600 | |
| $4.67 | +0.07 | +1.5% | $4.53 | $4.80 | $4.40 | 2,239,600 | |
| $4.60 | +0.15 | +3.4% | $4.66 | $4.83 | $4.28 | 4,425,600 | |
| $4.45 | +0.62 | +16.2% | $3.86 | $4.52 | $3.86 | 4,994,700 | |
| $3.83 | +0.21 | +5.8% | $3.65 | $3.85 | $3.59 | 868,600 | |
| $3.62 | -0.07 | -1.9% | $3.71 | $3.72 | $3.51 | 584,100 | |
| $3.69 | -0.16 | -4.2% | $3.85 | $3.86 | $3.63 | 823,600 | |
| $3.85 | +0.05 | +1.3% | $3.80 | $3.92 | $3.79 | 546,100 | |
| $3.80 | -0.31 | -7.5% | $4.17 | $4.21 | $3.77 | 908,700 | |
| $4.11 | +0.08 | +2.0% | $4.07 | $4.42 | $4.04 | 1,496,000 | |
| $4.03 | -0.02 | -0.5% | $4.02 | $4.24 | $3.82 | 812,200 | |
| $4.05 | -0.07 | -1.7% | $4.16 | $4.33 | $4.02 | 1,045,000 | |
| $4.12 | +0.05 | +1.2% | $4.01 | $4.26 | $4.01 | 1,461,500 | |
| $4.07 | +0.38 | +10.3% | $3.76 | $4.08 | $3.76 | 732,000 | |
| $3.69 | +0.04 | +1.1% | $3.65 | $3.71 | $3.59 | 752,900 | |
| $3.65 | +0.04 | +1.1% | $3.60 | $3.75 | $3.55 | 608,400 | |
| $3.61 | -0.11 | -3.0% | $3.74 | $3.75 | $3.56 | 414,200 | |
| $3.72 | -0.04 | -1.1% | $3.78 | $3.87 | $3.70 | 513,300 | |
| $3.76 | -0.12 | -3.1% | $3.90 | $3.99 | $3.75 | 480,300 | |
| $3.88 | +0.22 | +6.0% | $3.67 | $3.91 | $3.60 | 538,300 | |
| $3.66 | 0.00 | 0.0% | $3.63 | $3.78 | $3.62 | 607,900 | |
| $3.66 | -0.06 | -1.6% | $3.73 | $3.75 | $3.53 | 915,200 | |
| $3.72 | -0.06 | -1.6% | $3.74 | $3.96 | $3.55 | 681,100 | |
| $3.78 | +0.07 | +1.9% | $3.74 | $3.82 | $3.58 | 872,200 | |
| $3.71 | +0.07 | +1.9% | $3.67 | $3.72 | $3.61 | 718,500 | |
| $3.64 | -0.07 | -1.9% | $3.72 | $3.79 | $3.54 | 1,731,500 | |
| $3.71 | -0.13 | -3.4% | $3.86 | $3.86 | $3.62 | 970,400 | |
| $3.84 | +0.37 | +10.7% | $3.46 | $3.88 | $3.42 | 1,036,700 |
- Ticker
- NASDAQ:IRD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
Latest deck · Oct 15, 2026
Retina in Rio 2026
Conference · 25 slides
Latest news
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
Oct 29, 2026
Closed $3.65 (-0.8%) on Oct 29, 2026
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
Oct 21, 2026
Closed $4.12 (+2.6%) on Oct 21, 2026
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
Oct 16, 2026
Closed $3.84 (-5.2%) on Oct 16, 2026
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
Oct 15, 2026
Closed $3.84 (-5.2%) on Oct 16, 2026
Opus Genetics to Present at the Chardan Annual Healthcare Conference
Oct 13, 2026
Closed $4.24 (-8.6%) on Oct 13, 2026
Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027
Sep 9, 2026
Closed $5.73 (+32.0%) on Sep 9, 2026
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
Sep 2, 2026
Closed $4.45 (+16.2%) on Sep 2, 2026
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
Aug 6, 2026
Closed $3.72 (-1.6%) on Aug 6, 2026
Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease
Aug 3, 2026
Closed $3.64 (-1.9%) on Aug 3, 2026
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
Jul 9, 2026
Closed $4.02 (-2.0%) on Jul 9, 2026
Decks
Retina in Rio 2026
Conference · 25 slides · Oct 15, 2026
Corporate Update (October 2026)
Corporate update · 12 slides · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 50 slides · October 2026
Euretina 2026
Conference · 11 slides · October 2026
Opus Genetics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 75 in all · newest Oct 29, 2026 · oldest 2021
- Decks
- 32 decks · latest Oct 15, 2026
Where Opus Genetics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IRD · Home listing · This page | NASDAQ | United States | USD |
| gettex:R3X1 | gettex | Germany | EUR |
| LS Exchange:A2QG4Z | LS Exchange | Germany | EUR |
| Frankfurt:R3X1 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QG4Z | Lang & Schwarz | Germany | EUR |
| BOATS:IRD | BOATS | United States | USD |
| Tradegate:R3X1 | Tradegate | Germany | EUR |
| Dusseldorf:R3X1 | Dusseldorf | Germany | EUR |
| Munich:R3X1 | Munich | Germany | EUR |
| Stuttgart:R3X1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Opus Genetics, Inc.